NCT03458897View on ClinicalTrials.gov

Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant

NACompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

May 3, 2018

Primary Completion Date

August 16, 2020

Study Completion Date

September 1, 2020

Conditions
Sickle Cell Disease
Interventions
DIAGNOSTIC_TEST

serial functional magnetic resonance imaging (MRI)

All subjects with sickle cell disease undergoing bone marrow transplantation will undergo up to 4 functional MRI scans.

Trial Locations (1)

48109

University of Michigan, Ann Arbor

All Listed Sponsors
lead

University of Michigan

OTHER

NCT03458897 - Quantitative MRI for Patients With Sickle Cell Disease Undergoing Hematopoietic Cell Transplant | Biotech Hunter | Biotech Hunter